Logo for Journey Medical Corp

Journey Medical Corp Investor Relations Material

Latest events

Logo for Journey Medical Corp

Q4 2023

Journey Medical Corp
Logo for Journey Medical Corp

Q4 2023

21 Mar, 2024
Logo for Journey Medical Corp

Q3 2023

7 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Journey Medical Corp

Access all reports
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules.